Skip to main content
OpenTrials

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

3,317 public trials 609 recruiting studies
Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study

NCT02641405

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • IRCCS Santa Lucia Rome, Lazio, Italy
  • IRCCS National Neurological Institute "C. Mondino" Foundation Pavia, PV, Italy
  • Istituto Auxologico Italiano Oggebbio, Verbano-Cusio-Ossola, Italy
  • IRCCS San Raffaele Cassino, Italy
View Trial Details
Completed

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

NCT01474421

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Manhasset, New York, United States
  • Novartis Investigative Site Cincinnati, Ohio, United States
  • Novartis Investigative Site Cleveland, Ohio, United States
View all 24 locations
View Trial Details
Completed

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01491932

Conditions
Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • Novartis Investigative Site Englewood, Colorado, United States
  • Novartis Investigative Site Kansas City, Kansas, United States
  • Novartis Investigative Site Milwaukee, Wisconsin, United States
  • Novartis Investigative Site Innsbruck, Austria
View all 32 locations
View Trial Details
Completed

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01173731

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations
  • Novartis Investigative Site Sunnyvale, California, United States
  • Novartis Investigative Site Englewood, Colorado, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Heidelberg, Victoria, Australia
View all 22 locations
View Trial Details

Related conditions